Columbia Contrarian Core Fund EBIT

Columbia Contrarian Core Fund (CORRX) currently reports a EBIT of $-22M as of August 2022. In the prior-year period, the figure was $0. That is below the sector sector average of $2.5T. Use the charts on this page to explore Columbia Contrarian Core Fund's EBIT history and peer comparisons.

Columbia Contrarian Core Fund's EBIT changed from $0 to $-22M (period ending August 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Columbia Contrarian Core Fund's EBIT of $-22M is lower than the its sector sector average of $2.5T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Columbia Contrarian Core Fund reported $-22M in EBIT as of August 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-22M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for Columbia Contrarian Core Fund, and consider following CORRX for alerts when major investors trade the stock.